KR20230061474A - 소형화 시티딘 데아미나아제를 포함하는 이중쇄 dna의 개변용 복합체 - Google Patents

소형화 시티딘 데아미나아제를 포함하는 이중쇄 dna의 개변용 복합체 Download PDF

Info

Publication number
KR20230061474A
KR20230061474A KR1020237011179A KR20237011179A KR20230061474A KR 20230061474 A KR20230061474 A KR 20230061474A KR 1020237011179 A KR1020237011179 A KR 1020237011179A KR 20237011179 A KR20237011179 A KR 20237011179A KR 20230061474 A KR20230061474 A KR 20230061474A
Authority
KR
South Korea
Prior art keywords
amino acid
acid sequence
deaminase
lys
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237011179A
Other languages
English (en)
Korean (ko)
Inventor
케이지 니시다
앙 리
히토시 미츠노부
Original Assignee
고쿠리츠다이가쿠호진 고베다이가쿠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고쿠리츠다이가쿠호진 고베다이가쿠 filed Critical 고쿠리츠다이가쿠호진 고베다이가쿠
Publication of KR20230061474A publication Critical patent/KR20230061474A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y305/00Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/04Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
    • C12Y305/04005Cytidine deaminase (3.5.4.5)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
KR1020237011179A 2020-09-04 2021-09-06 소형화 시티딘 데아미나아제를 포함하는 이중쇄 dna의 개변용 복합체 Pending KR20230061474A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020149419 2020-09-04
JPJP-P-2020-149419 2020-09-04
PCT/JP2021/032689 WO2022050413A1 (ja) 2020-09-04 2021-09-06 小型化シチジンデアミナーゼを含む二本鎖dnaの改変用複合体

Publications (1)

Publication Number Publication Date
KR20230061474A true KR20230061474A (ko) 2023-05-08

Family

ID=80492029

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237011179A Pending KR20230061474A (ko) 2020-09-04 2021-09-06 소형화 시티딘 데아미나아제를 포함하는 이중쇄 dna의 개변용 복합체

Country Status (9)

Country Link
US (1) US20230323335A1 (https=)
EP (1) EP4209589A4 (https=)
JP (1) JPWO2022050413A1 (https=)
KR (1) KR20230061474A (https=)
CN (1) CN116134141A (https=)
AU (1) AU2021336262A1 (https=)
BR (1) BR112023003972A2 (https=)
CA (1) CA3194019A1 (https=)
WO (1) WO2022050413A1 (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003087341A2 (en) 2002-01-23 2003-10-23 The University Of Utah Research Foundation Targeted chromosomal mutagenesis using zinc finger nucleases
WO2011072246A2 (en) 2009-12-10 2011-06-16 Regents Of The University Of Minnesota Tal effector-mediated dna modification
WO2013176772A1 (en) 2012-05-25 2013-11-28 The Regents Of The University Of California Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1856576B (zh) 2003-09-30 2011-05-04 宾夕法尼亚州立大学托管会 腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
WO2010012077A1 (en) 2008-07-28 2010-02-04 Mount Sinai Hospital Compositions, methods and kits for reprogramming somatic cells
JP2013128413A (ja) 2010-03-11 2013-07-04 Kyushu Univ Pprモチーフを利用したrna結合性蛋白質の改変方法
US11685935B2 (en) * 2013-05-29 2023-06-27 Cellectis Compact scaffold of Cas9 in the type II CRISPR system
SG11201609211VA (en) 2014-03-05 2016-12-29 Nat Univ Corp Univ Kobe Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
JP2020510439A (ja) * 2017-03-10 2020-04-09 プレジデント アンド フェローズ オブ ハーバード カレッジ シトシンからグアニンへの塩基編集因子
CA3057192A1 (en) * 2017-03-23 2018-09-27 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable dna binding proteins
US20200172895A1 (en) * 2017-05-25 2020-06-04 The General Hospital Corporation Using split deaminases to limit unwanted off-target base editor deamination
JP6727680B2 (ja) 2018-03-26 2020-07-22 国立大学法人神戸大学 細胞の有する二本鎖dnaの標的部位を改変する方法
JP7487939B2 (ja) * 2018-11-01 2024-05-21 国立大学法人 東京大学 2分割されたCpf1タンパク質
KR20210121113A (ko) * 2019-01-31 2021-10-07 빔 테라퓨틱스, 인크. 비-표적 탈아미노화가 감소된 핵염기 편집기 및 핵염기 편집기를 특성규명하기 위한 분석
KR20210139265A (ko) * 2019-02-13 2021-11-22 빔 테라퓨틱스, 인크. 표적 서열에서 핵염기를 변형하기 위한 아데노신 데아미나제 염기 편집기 및 이의 사용 방법
JP7234711B2 (ja) 2019-03-14 2023-03-08 富士フイルムビジネスイノベーション株式会社 メッセージ通知装置、コンテンツ管理システム及びプログラム

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003087341A2 (en) 2002-01-23 2003-10-23 The University Of Utah Research Foundation Targeted chromosomal mutagenesis using zinc finger nucleases
WO2011072246A2 (en) 2009-12-10 2011-06-16 Regents Of The University Of Minnesota Tal effector-mediated dna modification
WO2013176772A1 (en) 2012-05-25 2013-11-28 The Regents Of The University Of California Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Cong, L. et al., Science 339(6121):819-823(2013)
Mali, P. et al., Science 339(6121):823-826(2013)
Nishida, K. et al., Science 353(6305):aaf8729(2016)
Tan J. et al., Nat Commun. 10(1):439(2019)

Also Published As

Publication number Publication date
AU2021336262A1 (en) 2023-05-18
EP4209589A4 (en) 2024-09-25
AU2021336262A9 (en) 2024-09-05
WO2022050413A1 (ja) 2022-03-10
US20230323335A1 (en) 2023-10-12
BR112023003972A2 (pt) 2023-04-18
CA3194019A1 (en) 2022-03-10
EP4209589A1 (en) 2023-07-12
JPWO2022050413A1 (https=) 2022-03-10
CN116134141A (zh) 2023-05-16

Similar Documents

Publication Publication Date Title
KR101958437B1 (ko) Cpf1을 포함하는 유전체 교정용 조성물 및 그 용도
US20240392304A1 (en) Circular rna and preparation method thereof
CN114634923B (zh) 腺苷脱氨酶、碱基编辑器融合蛋白、碱基编辑器系统及用途
US20250066751A1 (en) Cas9-Cas9 Fusion Proteins
KR102647766B1 (ko) 클래스 ii, 타입 v crispr 시스템
KR102093570B1 (ko) 조작된 핵산 표적화 핵산
KR102210322B1 (ko) Rna-안내 게놈 편집의 특이성을 증가시키기 위한 rna-안내 foki 뉴클레아제(rfn)의 용도
EP3916086A1 (en) Nucleic acid-guided nucleases
KR102387830B1 (ko) 안정하고 부작용이 적은 게놈 편집용 복합체 및 이를 코딩하는 핵산
JP2024504981A (ja) 新規の操作されたヌクレアーゼおよびキメラヌクレアーゼ
JP6727680B2 (ja) 細胞の有する二本鎖dnaの標的部位を改変する方法
JP2024522171A (ja) Dna改変のためのcrispr-トランスポゾンシステム
AU2022292659A1 (en) Systems, methods, and compositions comprising miniature crispr nucleases for gene editing and programmable gene activation and inhibition
CA2939541C (en) Hybrid proteins and uses thereof
AU2022284808A1 (en) Class ii, type v crispr systems
WO2004033633A2 (en) Compatible host/vector systems for expression of dna
US20190218533A1 (en) Genome-Scale Engineering of Cells with Single Nucleotide Precision
KR20230061474A (ko) 소형화 시티딘 데아미나아제를 포함하는 이중쇄 dna의 개변용 복합체
CN114207125B (zh) 通过抑制条件性必需基因进行反向选择
US20260043048A1 (en) High-throughput in vivo dna recombineering
WO2020096492A1 (en) Dna vector for targeted gene therapy
KR20200078200A (ko) 크리스퍼 연관 단백질 및 엑소뉴클레아제를 포함하는 변형된 크리스퍼 연관 단백질
Simons et al. Identification of Vibrio natriegens uvrA and uvrB genes and analysis of gene regulation using transcriptional reporter plasmids
HK1062034B (en) Use of multiple recombination sites with unique specificity in recombinational cloning
HK1062034A1 (zh) 具有独特特异性的多个重组位点在重组克隆中的用途

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20230331

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20240716

Comment text: Request for Examination of Application